Open menu
Paytm Money logo
search-placeholder
search
Mutual Fund Details
search-placeholder
search
Nippon India Mutual Fund

Nippon India Pharma Fund Direct - Growth

NAV
returns change indicator
235.7314
as on 29 Oct 2020, 10:50 PM
-2.0703(0.87%)
Last Change
loaderloader

Start SIP in this Mutual Fund

Min SIP Amount
100
Suggested Date
2nd of Every Month

Investment Performance

would have given a return of
110,871
star
121,647
star
166,694
star
171,083
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
71,083
Profit (absolute return)
71.08%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money

Investment Returns

In the last 3 months
10.49%
In the last 6 months
23.31%
In the last 1 year
51.72%
In the last 3 years
71.08%
In the last 5 years
47.84%
In the last 10 years
NA
Absolute Returns
CAGR

Scheme Riskometer

low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk

Scheme Information

Nippon India Pharma Fund Direct - Growth
Nippon India Pharma Fund Direct - Growth
as of 30 Sep 2020, 05:30 AM
3,910.67 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 month.
1.16%
Expense Ratio
Plan
Growth
3.31%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 month.
Scheme Document

Sectors Holding in this Mutual Fund

as on 30 Sep 2020
Sort By
Healthcare
96.40%
3,769.88 Cr
Cash Holding
3.31%
129.44 Cr

Companies Holding in this Mutual Fund

as on 30 Sep 2020
Sort By
Lupin Ltd.
10.30%
402.80 Cr
Aurobindo Pharma Ltd.
10.00%
391.07 Cr
Sun Pharmaceutical Inds. Ltd.
9.73%
380.51 Cr
Dr. Reddy's Laboratories Ltd.
9.62%
376.21 Cr
Divi's Laboratories Ltd.
9.35%
365.65 Cr
Cipla Ltd.
9.31%
364.08 Cr
Thyrocare Technologies Ltd.
5.54%
216.65 Cr
Fortis Healthcare (India) Ltd
4.98%
194.75 Cr
Cadila Healthcare Ltd.
4.04%
157.99 Cr
Sanofi India Ltd.
3.87%
151.34 Cr
View All
View All

About Nippon India Pharma Fund Direct - Growth

Nippon India Pharma Fund Direct - Growth is a Equity mutual fund scheme from Nippon India Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager Sailesh Raj Bhan. It has an AUM of ₹3,910.67 Crores and the latest NAV decalared is ₹235.731 as on 30 Oct 2020 at 3:56 pm.
Nippon India Pharma Fund Direct - Growth scheme return performance in last 1 year is 51.72%, in last 3 years is 71.08% and 237.41% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.

Scheme Details

AUM:3,910.67 Cr
Category:Equity: Sectoral-Pharma
Launch Date:01 Jan 2013
Fund Type:Open-End

Scheme Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

AMC Information

Nippon India Mutual Fund
Nippon India Mutual Fund
View AMC Details
195,246.97 Cr
AUM
198
Schemes
Address
Address
Reliance Centre, 7th Floor, South WingOff Western Express HighwaySantacruz (East)400055
Phone Number
Phone Number
Phone : 022-68334800 / 18602660111
Fax : 022-33037662